Mostrar el registro sencillo del ítem
dc.contributor.author | Aspland, Avrill M | |
dc.contributor.author | Douagi, Iyadh | |
dc.contributor.author | Filby, Andrew | |
dc.contributor.author | Jellison, Evan R | |
dc.contributor.author | Martinez Garcia, Maria Dolores | |
dc.contributor.author | Shinko, Diana | |
dc.contributor.author | Smith, Adrian L | |
dc.contributor.author | Tang, Vera A | |
dc.contributor.author | Thornton, Sherry | |
dc.date.accessioned | 2024-02-02T10:26:20Z | |
dc.date.available | 2024-02-02T10:26:20Z | |
dc.date.issued | 2021-01 | |
dc.identifier.citation | Cytometry A . 2021;99(1):68-80. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/17426 | |
dc.description.abstract | Biosafety has always been an important aspect of daily work in any research institution, particularly for cytometry Shared Resources Laboratories (SRLs). SRLs are common-use spaces that facilitate the sharing of knowledge, expertise, and ideas. This sharing inescapably involves contact and interaction of all those within this working environment on a daily basis. The current pandemic caused by SARS-CoV-2 has prompted the re-evaluation of many policies governing the operations of SRLs. Here we identify and review the unique challenges SRLs face in maintaining biosafety standards, highlighting the potential risks associated with not only cytometry instrumentation and samples, but also the people working with them. We propose possible solutions to safety issues raised by the COVID-19 pandemic and provide tools for facilities to adapt to evolving guidelines and future challenges. | es_ES |
dc.description.sponsorship | National Institute of Allergy and Infectious Diseases | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject.mesh | COVID-19 | es_ES |
dc.subject.mesh | Containment of Biohazards | es_ES |
dc.subject.mesh | Flow Cytometry | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Laboratories | es_ES |
dc.subject.mesh | Risk Assessment | es_ES |
dc.title | Biosafety during a pandemic: shared resource laboratories rise to the challenge. | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.identifier.pubmedID | 33289290 | es_ES |
dc.format.volume | 99 | es_ES |
dc.format.number | 1 | es_ES |
dc.format.page | 68 | es_ES |
dc.identifier.doi | 10.1002/cyto.a.24280 | es_ES |
dc.contributor.funder | NIH - National Cancer Institute (NCI) (Estados Unidos) | es_ES |
dc.description.peerreviewed | No | es_ES |
dc.identifier.e-issn | 1552-4930 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1002/cyto.a.24280. | es_ES |
dc.identifier.journal | Cytometry. Part A : the journal of the International Society for Analytical Cytology | es_ES |
dc.repisalud.institucion | CNIO | es_ES |
dc.repisalud.orgCNIO | CNIO::Unidades técnicas::Unidad de Citometría de Flujo | es_ES |
dc.rights.accessRights | open access | es_ES |